Indeed, Fang and colleagues described that TRPV4 inhibition in vitro depleted cell proliferation, reduced EMT, and led to apoptosis via downregulation of p-ERK while also suppressing tumor growth in xenograft models in vivo [99]. Here, TRPV4 is linked to neoplasm.